Back to Trades
Kaye Mark
DirectorCIK: 0001748691
Kaye Mark, Director, has filed 2 insider trading reports covering 2 companies. Total disclosed trading volume is $985.0K. Purchases and sales are approximately balanced over this period. The largest single filing involves Elevance Health, Inc. (ELV). All transactions sourced from SEC Form 4 filings.
Total Volume
$985.0K
Purchases
$0
Sales
$0
Companies
2
Companies Traded
Trading History (2 filings)
Other
$0
Other
$0